CY1112539T1 - Νεες ενωσεις μορφινης για φαρμακευτικες συνθεσεις - Google Patents

Νεες ενωσεις μορφινης για φαρμακευτικες συνθεσεις

Info

Publication number
CY1112539T1
CY1112539T1 CY20121100237T CY121100237T CY1112539T1 CY 1112539 T1 CY1112539 T1 CY 1112539T1 CY 20121100237 T CY20121100237 T CY 20121100237T CY 121100237 T CY121100237 T CY 121100237T CY 1112539 T1 CY1112539 T1 CY 1112539T1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical compositions
new
morphine compounds
new morphine
compounds
Prior art date
Application number
CY20121100237T
Other languages
English (en)
Inventor
Rainer Trittler
Original Assignee
Universitätsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitätsklinikum Freiburg filed Critical Universitätsklinikum Freiburg
Publication of CY1112539T1 publication Critical patent/CY1112539T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Η εφεύρεση αφορά νέες ενώσεις μορφίνης του τύπου: όπου το R1 παριστάνει ένα C1-6-αλκύλιο και οι ρίζες R2 και R3, ανεξάρτητα η μία από την άλλη, επιλέγονται από την ομάδα που αποτελείται από άτομα υδρογόνου, μεθυλομάδες και ακετυλομάδες.
CY20121100237T 2006-03-02 2012-03-08 Νεες ενωσεις μορφινης για φαρμακευτικες συνθεσεις CY1112539T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06004218A EP1829878A1 (de) 2006-03-02 2006-03-02 Neue Morphinverbindungen für pharmazeutische Zusammensetzungen
EP07711544A EP1989208B1 (de) 2006-03-02 2007-02-15 Neue morphinverbindungen für pharmazeutische zusammensetzungen

Publications (1)

Publication Number Publication Date
CY1112539T1 true CY1112539T1 (el) 2015-12-09

Family

ID=36678305

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100237T CY1112539T1 (el) 2006-03-02 2012-03-08 Νεες ενωσεις μορφινης για φαρμακευτικες συνθεσεις

Country Status (10)

Country Link
US (1) US8039640B2 (el)
EP (2) EP1829878A1 (el)
AT (1) ATE544768T1 (el)
CY (1) CY1112539T1 (el)
DK (1) DK1989208T3 (el)
ES (1) ES2379397T3 (el)
PL (1) PL1989208T3 (el)
PT (1) PT1989208E (el)
SI (1) SI1989208T1 (el)
WO (1) WO2007098860A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8461171B2 (en) * 2010-02-09 2013-06-11 QRxPharma Ltd. Hybrid opioid compounds and compositions
US20180363839A1 (en) * 2017-06-14 2018-12-20 O2Cool, Llc Beverage Clip

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1709957A3 (en) * 2001-06-05 2007-02-14 Control Delivery Systems Sustained-release analgesic compounds

Also Published As

Publication number Publication date
US20090012110A1 (en) 2009-01-08
EP1989208B1 (de) 2012-02-08
US8039640B2 (en) 2011-10-18
PL1989208T3 (pl) 2012-05-31
EP1829878A1 (de) 2007-09-05
ATE544768T1 (de) 2012-02-15
WO2007098860A1 (de) 2007-09-07
SI1989208T1 (sl) 2012-03-30
PT1989208E (pt) 2012-03-23
EP1989208A1 (de) 2008-11-12
DK1989208T3 (da) 2012-03-05
ES2379397T3 (es) 2012-04-25

Similar Documents

Publication Publication Date Title
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
TW200833682A (en) Pharmaceutical compounds
NO20080789L (no) 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid
TNSN08407A1 (en) Organic compounds
ATE457302T1 (de) Aromatische etherderivate als thrombin-hemmer
WO2005074642A3 (en) Chemical compounds
BRPI0719393B8 (pt) composição farmacêutica
NO20076498L (no) Derivater av 4-(2-amino-1-hydroksyetyl)fenol som agonister av den betta2-adrenerge reseptoren
MX2007007956A (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
HK1165426A1 (en) Methods of synthesizing pharmaceutical salts of a factor xa inhibitor xa
WO2009154754A3 (en) Synthesis of deuterated morpholine derivatives
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
EA200870224A1 (ru) Бензо[f]изоиндол-2-илфенильные производные уксусной кислоты в качестве агонистов рецепторов ep
CY1112539T1 (el) Νεες ενωσεις μορφινης για φαρμακευτικες συνθεσεις
WO2008141097A3 (en) Stereoisomers propofol therapeutic compounds
WO2007133481A3 (en) Method for increasing the bioavailability of benzhydryl piperazine containing compounds
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
WO2007085651A8 (en) Process for the stereoselective preparation of alcohols from alpha, beta- insaturated compounds
MX2007007899A (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE469156T1 (de) 3,4 diaminopyridin-derivate
WO2006109146A3 (en) Novel heterocyclic derivatives
DE602007003207D1 (de) Heterocyclische modulatoren für den gaba-alpha-subtyp-selektiven rezeptor
ATE522530T1 (de) 2-piperazin-1-yl-3h-imidazoä4,5-bü- pyridinderivate
MX2007012608A (es) Derivados de 1[(5-r1-tiofen-; furan)-2-il-metilen]-2-[(r2)fenil] hidrazona, su metodo de obtencion y su uso para la preparacion de medicamentos para el mal de chagas.
WO2012037069A3 (en) Unique halogen-induced cyclizations, reagents therefor, and compounds produced thereby